Trials
4 active
6 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “HS-10506: Administered under fasting conditions in the morning. Itraconazole: Itraconazole capsules (0.2 g) are taken orally once daily for nine consecutive days.”In the company’s words, NCT07535970 on ClinicalTrials.gov
- Tested for
- Insomnia Disorder (2 trials), Hepatic Impairment (Moderate or Mild) & Normal Hepatic Function
- Main trialPhase 3
- “The primary purpose of this phase 3 study is to evaluate the safety and the efficacy of HS-10506 (change versus placebo) on latency to persistent sleep (LPS) and wakefulness after sleep onset (WASO) measured by polysomnography (PSG) in Chinese adult participants with insomnia disorder.”In the company’s words, NCT07587385 on ClinicalTrials.gov
Other drugs for Insomnia Disorder
- RamelteonNanjing Chia-tai Tianqing Pharmaceutical · Phase 3
- SolriamfetolAxsome Therapeutics, Inc. · Phase 3
- SuvorexantMerck & Co. · Phase 3
- CBD TPMAvecho Biotechnology · Phase 3
- TasimelteonVanda Pharmaceuticals · Phase 3
- SOM001-ASomnum Pharma Inc. · Phase 2
Coming up3
- 1 Jun 2028Phase 1 trial completes · ClinicalTrials.gov
- 28 Jun 2028Phase 3 trial completes · ClinicalTrials.gov
- 30 Jun 2029Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | 28 Jun 2028 | A Study of HS-10506 in Chinese Patients With Insomnia Disorder | |
| Phase 3Not yet recruiting | 30 Jun 2029 | A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder | |
| Phase 1Not yet recruiting | 30 Jul 2026 | A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants | |
| Phase 1Recruiting | 1 Jun 2028 | A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506 | |
| Phase 1/2Unknown | Jan 2025 | Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder | |
| Phase 1Unknown | 24 Dec 2023 | Phase 1a Study in Healthy Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026